RESEARCH AND INSIGHT

gene

Genomic Medicine：the Era of Single Cell Omics

Genomics, derived and developed from genetics in the 19th century, has experienced many paradigm changes, just like the development of the discipline of need. This is due to the development and integration of other disciplines and technological innovation, but the fundamental motivation has never ch...

2021-08-04

Genomics

Scientometrics analysis of single cell sequencing research （2016-2021）

Single cell sequencing promotes the development of genomic medicine. This research report has extracted literature data from the Web of Science Core Database, and briefly analyzed the main papers in this field from 2016 to 2021 based on scientometric methodology.

2021-07-01

COVID-19

Antigen detection, antibodies, vaccines and drugs: multiple battlefields against novel coronavirus

For people infected with novel coronavirus, rapid and accurate serological screening is very important for large-scale epidemiological evaluation and intervention. The prevalence rate in Slovakia is relatively high (about 3.9%), large-scale rapid detection of novel coronavirus in this country can id...

2021-06-28

Artificial Intelligence

AI and Clinical Research: the Possibility of Decision Accuracy

Clinical research is the test of the medications to achieve real application. After leaving the limited space of cells and the ideal animal models, the effect and safety of the medications after entering the human body is a complex issue, which is affected by many factors such as individual biology,...

2021-06-27

Ageing

Aging: a kind of underlying logic for understanding diseases

It seems that how Alzheimer's disease occurs and how to choose treatment has always been a problem for countless people. It is not only a logical problem of chicken or egg first, but also a philosophical problem of appearance and essence. In addition to the treatment dilemma that makes scientists sc...

2021-06-25

Cancer

Tumor metastasis: the secret of time and space

For the treatment of primary tumors, there are many methods: surgical resection as the first-line treatment, combined with radiotherapy, chemotherapy, and targeted therapy as the back-line or adjuvant treatment. These methods have formed a paradigm for the treatment of solid tumors. However, for met...

2021-06-24

Pharmaceutical

Inspiration of film to pharmaceutical industry

In 2021, the article of The Economist "Go small: The new economics of blockbusters" talked that (1), during the period of COVID-19, the scarcity of movie blockbusters is reshaping box office economics. It may point to another option, that is with the reduction of large production, the productio...

2021-06-23

Biotechnology

Which biotechnology and companies continue to receive attention？

The sudden COVID-19 epidemic has brought the largest recession to the global economy since World War II. A report so-called the target Guardian report released from Bill & Melinda Gates Foundation shows that the global GDP loss is twice that of the 2008 economic crisis. Data from ...

2021-06-23

Gene Therapy

Adeno-associated virus gene therapy

The gene therapy model using adeno-associated virus (AAV) has gradually entered the stage of commercial development. Analysis of 149 studies of AAV gene therapy showed that 59 of them reached the clinical end point. The modification of AAV capsids (AAV2, AAV8, AAV9, AAV-LK03, SPK-100 and AAV-HSC15) ...

2021-06-22
MORE
BACK

© 2022 CAVALIER PERSPECTIVE. All rights reserved. 沪ICP备2021024167号-1


Disclaimer and Agreement

CAVALIER PERSPECTIVE is a medical technology knowledge and opinion management organization. CAVALIER PERSPECTIVE mainly analyzes and shares medical technology knowledge and opinions, and helps scientists engaged in translational medicine research and entrepreneurs in biomedical companies to carry out knowledge innovation, technological innovation and product innovation. Currently, it is unable to provide consulting and business services for most organizations and customers. The website provides information for potential customers, such as researchers, scientists, students, business managers, and industry-related personnel. In any case, any information contained on this website shall not be sold for commercial purposes. This website does not contain any unauthorized data and patents of customers. Some research reports and data provided on this website may not be available to the public without authorization.

To view this content, in addition to using the CAVALIER PERSPECTIVE terms and privacy policy, you must agree to the following terms:

I confirm and agree to CAVALIER PERSPECTIVE:

  • I entered this website only to obtain general information about CAVALIER PERSPECTIVE and not for any other purpose.
  • I understand that the personal data provided by CAVALIER PERSPECTIVE is not open to the public.
  • I understand that certain research report materials on this website will only be provided to a small number of people and organizations that meet the specified standards.
  • I understand that this website has not been reviewed or approved, submitted or otherwise provided by any government or similar agency, and the purpose of this website is only to provide to the public who have a legitimate interest in such information for reasons unrelated to investment Limited information.
  • I understand that when CAVALIER PERSPECTIVE provides third-party information, CAVALIER PERSPECTIVE usually does not have a verified statement made by a third party, and the presentation of information may omit important information.
  • I know that third-party materials, such as provided by on-site interviews or written in their own name, CAVALIER PERSPECTIVE usually does not make changes to these materials on the premise of determining the relevant topics. With the informed consent of the third party, they may be individually based on the semantic context. Sentence editing, which may include providing historical and professional background.
  • The content of CAVALIER PERSPECTIVE has proprietary intellectual property rights or third-party materials, including interviews and licensors of writing, etc. I will guarantee that I will not directly or indirectly copy, modify, rewrite, or create derivative works, including articles, social media , Publish, display, redistribute, disclose or provide content. For all or part of the website content, any content used for commercial purposes requires the written consent of CAVALIER PERSPECTIVE.

By registering the following my information and clicking "Agree", I guarantee that I have read:

Agree